Literature DB >> 9579951

Cause-specific mortality in epilepsy: a cohort study of more than 9,000 patients once hospitalized for epilepsy.

L Nilsson1, T Tomson, B Y Farahmand, V Diwan, P G Persson.   

Abstract

PURPOSE: We studied overall and cause-specific mortality rates in a large cohort of patients with epilepsy compared with mortality rates of the general population in the same geographic area.
METHODS: The cohort consisted of all patients (N = 9,061) aged > 15 years admitted with a diagnosis of epilepsy for inpatient care in Stockholm during the years 1980-1989. All patients were followed in the National Cause-of-Death Register, from which the causes of death were obtained, until December 31, 1992. Thus, 53,520 person-years were observed. Mortality rates were compared with those of the general population of Stockholm.
RESULTS: We observed 4,001 deaths in the cohort, compared with an expected number of 1,109 deaths in the general population. This yielded a standardized mortality ratio (SMR) of 3.6 [95% confidence interval (CI) 3.5-3.7]. Although highest in the younger patients, the SMR was significantly increased in all age groups. The excess mortality rate in the cohort was due to a wide range of causes of death, including malignant neoplasms [SMR 2.6 (2.4-2.8)], diseases of the circulatory system, [SMR 3.1 (3.0-3.3)], diseases of the respiratory system [SMR 4.0 (3.6-4.5)], diseases of the digestive system [SMR 5.1 (4.4-5.8)], and injuries and poisoning [SMR 5.6 (5.0-6.3)].
CONCLUSIONS: Our results demonstrate that this large subgroup of patients with a diagnosis of epilepsy, once hospitalized and discharged, is a population at risk, with an excess mortality rate due to several different causes.

Entities:  

Mesh:

Year:  1997        PMID: 9579951     DOI: 10.1111/j.1528-1157.1997.tb01194.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  48 in total

1.  Mortality in Epilepsy.

Authors:  Anne Berg
Journal:  Epilepsy Curr       Date:  2001-09       Impact factor: 7.500

2.  Paediatric postmarketing pharmacovigilance using prescription-event monitoring: comparison of the adverse event profiles of lamotrigine prescribed to children and adults in England.

Authors:  Beate Aurich-Barrera; Lynda Wilton; David Brown; Saad Shakir
Journal:  Drug Saf       Date:  2010-09-01       Impact factor: 5.606

Review 3.  Epilepsy: A Spectrum Disorder.

Authors:  Joseph I Sirven
Journal:  Cold Spring Harb Perspect Med       Date:  2015-09-01       Impact factor: 6.915

4.  Motor vehicle accidents, suicides, and assaults in epilepsy: a population-based study.

Authors:  C Kwon; M Liu; H Quan; V Thoo; S Wiebe; N Jetté
Journal:  Neurology       Date:  2011-02-02       Impact factor: 9.910

5.  Familial Liability to Epilepsy and Attention-Deficit/Hyperactivity Disorder: A Nationwide Cohort Study.

Authors:  Isabell Brikell; Laura Ghirardi; Brian M D'Onofrio; David W Dunn; Catarina Almqvist; Søren Dalsgaard; Ralf Kuja-Halkola; Henrik Larsson
Journal:  Biol Psychiatry       Date:  2017-08-12       Impact factor: 13.382

Review 6.  Epilepsy, depression, and growth hormone.

Authors:  Tracy Butler; Patrick Harvey; Lila Cardozo; Yuan-Shan Zhu; Adam Mosa; Emily Tanzi; Fahad Pervez
Journal:  Epilepsy Behav       Date:  2019-02-14       Impact factor: 2.937

Review 7.  The burden of premature mortality of epilepsy in high-income countries: A systematic review from the Mortality Task Force of the International League Against Epilepsy.

Authors:  David J Thurman; Giancarlo Logroscino; Ettore Beghi; W Allen Hauser; Dale C Hesdorffer; Charles R Newton; Fulvio Alexandre Scorza; Josemir W Sander; Torbjörn Tomson
Journal:  Epilepsia       Date:  2016-11-26       Impact factor: 5.864

8.  Is universal HLA-B*15:02 screening a cost-effective option in an ethnically diverse population? A case study of Malaysia.

Authors:  H Y Chong; Z Mohamed; L L Tan; D B C Wu; F H Shabaruddin; M Dahlui; Y D Apalasamy; S R Snyder; M S Williams; J Hao; L H Cavallari; N Chaiyakunapruk
Journal:  Br J Dermatol       Date:  2017-09-21       Impact factor: 9.302

Review 9.  [Sudden unexpected death in epilepsy (SUDEP) : Epidemiology, cardiac and other risk factors].

Authors:  Theodor W May; Carsten W Israel
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2019-09

Review 10.  [Depression and neurological diseases].

Authors:  D Piber; K Hinkelmann; S M Gold; C Heesen; C Spitzer; M Endres; C Otte
Journal:  Nervenarzt       Date:  2012-11       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.